• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Title: Charles Hoskinson Accuses President Biden of Efforts to Harm Crypto Industry

user avatar

by Giorgi Kostiuk

2 years ago


Cardano founder Charles Hoskinson criticized President Joe Biden, suggesting that the U.S. government is intentionally attempting to undermine the cryptocurrency industry within the nation. Hoskinson emphasized the government's detrimental impact on the industry, referencing various restrictions such as limited access to bank accounts and regulatory policies enforced by the Securities and Exchange Commission. Most recently, he highlighted the White House's interference in the legislative process related to cryptocurrencies. Specifically, the administration expressed opposition towards a resolution intended to reverse SEC guidelines discouraging banks from custodying digital assets. This statement came shortly after the House of Representatives approved a joint resolution to overturn a regulation known as SAB 121 which received strong opposition from the White House. Hoskinson further criticized the SEC for applying outdated laws to regulate modern asset classes, suggesting that this approach is unjustifiable. He also pointed out the favorable environment for crypto businesses in other countries like Switzerland, Singapore, and Dubai, hinting that the U.S. could have benefitted from these investments had the crypto policy been more rational. Despite some pushback on his remarks regarding the previous administration, Hoskinson maintained that the Biden government is actively seeking to suppress the crypto industry. In a previous incident, it was reported that the Biden Administration urged Congress to target the American Bitcoin mining sector, mirroring China's approach.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.